Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial

Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
American journal of obstetrics and gynecology (Impact Factor: 3.97). 03/2009; 200(6):634.e1-7. DOI: 10.1016/j.ajog.2009.01.003
Source: PubMed

ABSTRACT Women with previous gestational diabetes mellitus rarely receive the recommended 2-hour oral glucose tolerance test (OGTT) after delivery. We sought to determine whether postal reminders to be sent after delivery to a patient, her physician, or both would increase screening rates.
Patients were assigned randomly to 4 groups: reminders sent to both physician and patient, to physician but not patient, or to patient but not physician or no reminders were sent. The primary outcome was the proportion of patients who underwent an OGTT within 1 year after delivery. The secondary outcome was the performance of other postpartum screening tests.
OGTT rates were significantly increased in the physician/patient reminder group (49/81 women; 60.5%), in the patient-only reminder group (42/76 women; 55.3%), and in the physician-only reminder group (16/31 women; 51.6%) compared with the no reminder group (5/35 women; 14.3%; P < .05).
Postpartum reminders greatly increased screening rates for women with gestational diabetes mellitus.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Active cellular suicide by apoptosis plays important roles in animal development, tissue homeostasis and a wide variety of diseases, including cancer, AIDS, stroke and many neurodegenerative disorders. A central step in the execution of apoptosis is the activation of an unusual class of cysteine proteases, termed caspases, that are widely expressed as inactive zymogens. Originally, the mechanisms for regulating the caspase-based cell death programme seemed to be different in Caenorhabditis elegans, mammals and insects. However, recent results suggest that these apparent differences in the control of cell death reflect our incomplete knowledge, rather than genuine mechanistic differences between different organisms.
    Trends in Cell Biology 12/1999; 9(12):M49-52. DOI:10.1016/S0962-8924(99)01670-0 · 12.31 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The postpartum phase following gestational diabetes (GDM) is characterised by subtle metabolic defects, including the beta cell dysfunction that is believed to mediate the increased future risk of type 2 diabetes in this patient population. Low circulating levels of adiponectin and increased leptin and C-reactive protein (CRP) have recently emerged as novel diabetic risk factors, although their relevance to GDM and subsequent diabetes has not been characterised. Thus, we sought to determine whether adiponectin, leptin and CRP levels during pregnancy relate to the postpartum metabolic defects linking GDM with type 2 diabetes. Metabolic characterisation, including oral glucose tolerance testing, was undertaken in 487 women during pregnancy and at 3 months postpartum. Based on the antepartum OGTT, there were 137 women with GDM, 91 with gestational impaired glucose tolerance and 259 with normal glucose tolerance. Adiponectin levels were lowest (p < 0.0001) and CRP levels highest (p = 0.0008) in women with GDM. Leptin did not differ between the glucose tolerance groups (p = 0.4483). Adiponectin (r = 0.41, p < 0.0001), leptin (r = -0.36, p < 0.0001) and CRP (r = -0.30, p < 0.0001) during pregnancy were all associated with postpartum insulin sensitivity (determined using the insulin sensitivity index of Matsuda and DeFronzo [IS(OGTT)]). Intriguingly, adiponectin levels were also related to postpartum beta cell function (insulinogenic index/HOMA of insulin resistance; r = 0.16, p = 0.0009). Indeed, on multiple linear regression analyses, adiponectin levels during pregnancy independently predicted both postpartum insulin sensitivity (t = 3.97, p < 0.0001) and beta cell function (t = 2.37, p = 0.0181), even after adjustment for GDM. Furthermore, adiponectin emerged as a significant negative independent determinant of postpartum fasting glucose (t = -3.01, p = 0.0027). Hypoadiponectinaemia during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia, and hence may be relevant to the pathophysiology relating GDM with type 2 diabetes.
    Diabetologia 11/2009; 53(2):268-76. DOI:10.1007/s00125-009-1600-8 · 6.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: For over half a century, gestational diabetes mellitus (GDM) has been recognized as a risk factor for maternal diabetes after delivery or postpartum. GDM confers a 7-fold risk for future diabetes, independent of other significant risk factors such as weight, visceral adiposity, and physical activity. Up to a third of women with diabetes may have been affected by prior GDM. However, postpartum studies of GDM women are relatively few compared to prenatal and peripartum examinations. This chapter reviews methodological issues and risk factors affecting postpartum maternal diabetes risk estimates. The chapter also presents evidence regarding the risk for future cardiovascular disease among women with a GDM history. In doing, so, the chapter underlines the need for, and lack of: uniform diagnostic criteria and screening strategies for the index diagnosis of GDM as well as for postpartum glucose intolerance; quality improvement initiatives to improve postpartum glucose screening; and diabetes prevention interventions in this population. Perhaps most importantly, this chapter underlines the significance of GDM upon postpartum maternal glucose tolerance outside of pregnancy.
    12/2009: pages 301-315;


Available from